VOYA Investment Management’s Keros Therapeutics KROS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-29,488	Closed	-$467K	–	2690
2024 Q4	$467K	Sell	29,488 -145,806	-83%	-$7.58M	﹤0.01%	1965
2024 Q3	$10.2M	Buy	175,294 +119,197	+212%	+$5.89M	0.01%	759
2024 Q2	$2.56M	Sell	56,097 -3,176	-5%	-$171K	﹤0.01%	1240
2024 Q1	$3.92M	Buy	59,273 +25,638	+76%	+$1.52M	﹤0.01%	1096
2023 Q4	$1.34M	Sell	33,635 -38,511	-53%	-$1.21M	﹤0.01%	1523
2023 Q3	$2.3M	Buy	72,146 +154	+0.2%	+$5.75K	﹤0.01%	1277
2023 Q2	$2.89M	Buy	71,992 +1,808	+3%	+$79.3K	﹤0.01%	1210
2023 Q1	$3M	Hold	70,184	–	–	﹤0.01%	1185
2022 Q4	$3.37M	Sell	70,184 -17,226	-20%	-$805K	﹤0.01%	1121
2022 Q3	$3.29M	Buy	+87,410	New	+$3.03M	﹤0.01%	1129
2022 Q2	–	Sell	-6,131	Closed	-$333K	–	2837
2022 Q1	$333K	Hold	6,131	–	–	﹤0.01%	2126
2021 Q4	$359K	Buy	6,131 +25	+0.4%	+$1.25K	﹤0.01%	2200
2021 Q3	$242K	Hold	6,106	–	–	﹤0.01%	2467
2021 Q2	$259K	Buy	6,106 +122	+2%	+$6.61K	﹤0.01%	2455
2021 Q1	$368K	Buy	5,984 +504	+9%	+$31.9K	﹤0.01%	2194
2020 Q4	$387K	Buy	+5,480	New	+$345K	﹤0.01%	2063